SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Galapagos Islands -- Ignore unavailable to you. Want to Upgrade?


To: Jorj X Mckie who wrote (15836)12/9/2002 3:26:25 PM
From: Peach  Read Replies (1) | Respond to of 57110
 
Jorj, I would appreciate your looking at a GG chart when you have time.

Thank you.



To: Jorj X Mckie who wrote (15836)12/9/2002 3:27:06 PM
From: AugustWest  Read Replies (2) | Respond to of 57110
 
Well, I covered half my RFMD short.
No complaints here.
Still holding for a real flushing.

I don't think there will be any panic in the bulls till we break about 8300, 1300 on the comp.

BTW, why didn't someone kick me in the ass for buying those few shares of chkp?<GGG>
I'm going to hold them and average down about 12, 9, 6, 4, and 2.
Than I figure I'll panic and sell them about 1 1/2 :)



To: Jorj X Mckie who wrote (15836)12/9/2002 3:28:49 PM
From: Techplayer  Read Replies (1) | Respond to of 57110
 
13:28 ET Millennium Pharm plunges after Velcade data reported (MLNM) 9.69 -1.50: Stock has come under heavy sell pressure since the release of seemingly positive trial data. At this time, it is not clear exactly what is spooking investors. We are hearing that one reason for the sell-off could be the severity of toxicity reported in the Phase II trial.